ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2726

Differentiating Features of Primary Angiitis of Central Nervous System and Reversible Cerebral Vasoconstriction Syndrome: Clinical and Radiological Evaluation

Didem Saygin1, Russell Cerejo2, Priya Sundaram-Simonelli3, Gabor Toth4, Stephen Jones3, Leonard H. Calabrese5 and Rula A Hajj-Ali6, 1Internal Medicine, Department of Internal Medicine, Cleveland Clinic, Cleveland, Cleveland, OH, 2Cleveland Clinic, Cleveland, OH, 3Neuroradiology, Cleveland Clinic, Cleveland, OH, 4Cerebrovascular Center, Cleveland Clinic, Cleveland, OH, 5Rheumatic & Immunologic Disease and Infectious Disease, Cleveland Clinic Foundation, Cleveland, OH, 6Rheumatic and Immunologic Disease, Cleveland Clinic, Cleveland, OH

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Imaging and reversible cerebrovascular vasoconstriction

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Vasculitis Poster III: Other Vasculitis Syndromes

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Primary angiitis of central nervous system (PACNS) is an isolated vasculitis affecting small-sized cerebral blood vessels. One of the major mimickers of PACNS is reversible cerebral vasoconstriction syndrome (RCVS). Both entities have distinctive pathophysiology, prognosis and therapeutic implications and differentiation between both is prudent. In this study, we aimed  to compare the clinical  and imaging characteristics of PACNS and RCVS cases at the presentation to better differentiate these entities.

Methods: Patients from Cleveland Clinic prospective RCVS-PACNS registry were included in the study. PACNS cases were included if they had a biopsy consistent with vasculitis or positive angiography and inflammatory cerebrospinal fluid pattern. Patients were asked to fill out questionnaires regarding their symptoms at presentation, headache impact test (HIT-6) and migraine disability assesment test (MIDAS). Brain MRI and cerebral angiography performed near the time of presentation were blindly evaluated by one neuroradiologist and two interventional radiologists, respectively.

Results: Our study included 28 PACNS and 45 RCVS cases. Main results are summarized in table. Female patients were more commonly affected by RCVS compared to males (3.5:1). RCVS cases more commonly presented with headache than PACNS cases. Headache was often insidious and dull in PACNS, whereas it was sudden and thunderclap in RCVS. Time for headache to peak was reported as seconds and intensity of headache was higher in RCVS  cases.  Neurologic deficit was more commonly associated with headache in PACNS than RCVS cases.  

Appearance of vascular abnormality on cerebral angiogram was sausage-like in most of the RCVS and irregular in most of the PACNS cases. Subarachnoid hemorrhage was more common on MRI of RCVS cases, while nonspecific white matter changes were more common in PACNS cases. Lesions were superficial (involving cortex and subcortical white matter) in RCVS and deep (deep and periventricular white matter) in PACNS cases. Total score of MIDAS was higher in RCVS indicating more disability due to headache in these cases (p=0.01). Results of HIT-6 are shown in the figure.

Conclusion: PACNS cases experience insidious-onset and dull headache, while RCVS cases often experience sudden, more severe and disabling headache. Radiologic signs such as nonspecific white matter changes, deep location of lesion, and irregular appearance of the vessel on angiogram are more commonly seen in PACNS cases, and can help guide clinicians in differential diagnosis.

 

 

PACNS (n=28)

RCVS (n=45)

P value

Demographics

 Age

46.7±14.3

45.8±13.3

0.9

 Gender (F:M)

13:15

35:10

0.006

 Race (White/Black/Other)

27/0/1

38/6/1

0.1

Headache characteristics

 Presence of headache

18 (69.2%)

36 (97.3%)

0.001

 Insidious/Thunderclap headache

6/3

3/30

0.0002

 Time for headache to peak (hours/minutes/seconds)

3/2/1

1/4/21

0.002

 Intensity of headache (0-100)

51.1±22.6

75.4±25.1

0.01

 Dull headache

3 (30%)

1 (2.94%)

0.03

 Neurologic deficit associated with headache

15 (83.33%)

19 (52.77%)

0.03

 Exposure to vasoactive substance

3 (18.75%)

15 (53.12%)

0.03

Imaging characteristics

 Appearance of irregularity on cerebral angiogram (sausaging/irregular, notched)

4/7

27/1

<.0001

 Subarachnoid hemorrhage on MRI

1 (4.76%)

14 (41.17%)

0.004

 Non-specific white matter changes on MRI

7 (33.33%)

3 (8.82%)

0.03

 Superficial location of lesion on MRI

5 (15.15%)

14 (45.16%)

0.01

 Deep location of lesion on MRI

12 (36.36%)

5 (16.12%)

0.02


 

 

 

 

 

 


Disclosure: D. Saygin, None; R. Cerejo, None; P. Sundaram-Simonelli, None; G. Toth, None; S. Jones, None; L. H. Calabrese, Bristol-Myers Squibb, 5; R. A. Hajj-Ali, Abbvie, 8,Novartis Pharmaceutical Corporation, 5,GlaxoSmithKline, 5.

To cite this abstract in AMA style:

Saygin D, Cerejo R, Sundaram-Simonelli P, Toth G, Jones S, Calabrese LH, Hajj-Ali RA. Differentiating Features of Primary Angiitis of Central Nervous System and Reversible Cerebral Vasoconstriction Syndrome: Clinical and Radiological Evaluation [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/differentiating-features-of-primary-angiitis-of-central-nervous-system-and-reversible-cerebral-vasoconstriction-syndrome-clinical-and-radiological-evaluation/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/differentiating-features-of-primary-angiitis-of-central-nervous-system-and-reversible-cerebral-vasoconstriction-syndrome-clinical-and-radiological-evaluation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology